Drug Antibiotic Class Mode of Action Manufacturer Resistance?
Vabomere[^t2a] Beta-lactam + Beta-lactamase inhibitor “Combination of Meropenem and Vaborbactam” Melinta Yes[^t2b]
Baxdela[^t2c] Fluoroquinolone Bacterial Topoisomerase Inhibitor Melinta Yes[^t2d]
Xerava[^t2e] Halogenated-Tetracycline Inhibition of Bacterial Ribosomal S30 subunit Tetraphase Yes[^t2f]
Nuzyra[^t2g] Tetracycline Inhibition of Bacterial Ribosomal S30 subunit Paratek Yes[^t2h]
Sivextroi Oxazolidinone Inhibition of Bacterial Ribosomal S50 subunit Cubist Yes[^t2j]
Zerbaxa[^t2k] Cephalosporin + Beta-Lactamase inhibitor Combination of Ceftolozane and Tazobactam Cubist Yesl
Dalvance[^t2m] Lipoglycopeptide Interferes with peptidoglycan cross-links Allergan Yes[^t2n]
Oritavancin[^t2o] Lipoglycopeptide Interferes with peptidoglycan cross-links and bacterial RNA Melinta Yes[^t2p]
Avycaz[^t2q] Cephalosporin + Beta-lactamase inhibitor Combination of Ceftazidime and Avibactam Allergan Yes[^t2r]
Zemdri[^t2s] Aminoglycoside Inhibition of Bacterial Ribosomal S30 subunit Achaogen Yes[^t2t]
Recarbrio[^t2u] Carbapenem Betalactam + Renal Dehydropeptidase Inhibitor + Betalactamase inhibitor New combination of:
Imipenem – Old antibiotic that limits cell wall formation
Cilastatin- Limits kidneys from processing the antibiotic
Relebactam- Prevents Betalactamase from breaking down antibiotic
Merck Yes[^t2v]
Pretomanid[^t2w] Nitroimidazooxazine antibacterial Pretomanid blocks mycolic acid, wall formation TB-Alliance Yes[^t2x]
Xenleta[^t2y] Pleuromutilin antibacterial Novel* Inhibits the interactions on bacterial P and A sites of the 50S ribosomal subunit Nabriva Therapeutics Yes[^t2z]
Fetroja[^t2aa] Unique Cephalosporin Inhibits cell wall formation using bacterial “siderophore iron uptake mechanism” Shionogi Yes[^t2ab]